DNA methylation profiling reveals a predominant immune component in breast cancers

Breast cancer is a molecularly, biologically and clinically heterogeneous group of disorders. Understanding this diversity is essential to improving diagnosis and optimizing treatment. Both genetic and acquired epigenetic abnormalities participate in cancer, but the involvement of the epigenome in b...

Descripción completa

Detalles Bibliográficos
Autores principales: Dedeurwaerder, Sarah, Desmedt, Christine, Calonne, Emilie, Singhal, Sandeep K, Haibe-Kains, Benjamin, Defrance, Matthieu, Michiels, Stefan, Volkmar, Michael, Deplus, Rachel, Luciani, Judith, Lallemand, Françoise, Larsimont, Denis, Toussaint, Jérôme, Haussy, Sandy, Rothé, Françoise, Rouas, Ghizlane, Metzger, Otto, Majjaj, Samira, Saini, Kamal, Putmans, Pascale, Hames, Gérald, van Baren, Nicolas, Coulie, Pierre G, Piccart, Martine, Sotiriou, Christos, Fuks, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377115/
https://www.ncbi.nlm.nih.gov/pubmed/21910250
http://dx.doi.org/10.1002/emmm.201100801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377115/
https://www.ncbi.nlm.nih.gov/pubmed/21910250
http://dx.doi.org/10.1002/emmm.201100801

Ejemplares similares